[Drug-induced hemolytic anemia].
Acquired drug-related hemolytic anemia is mainly induced by immune mechanism or microvascular lesion. Three mechanisms of drug-related immunologic injury to red blood cells are recognized. They are hapten or drug adsorption mechanism, ternary or drug-antibody-target cell complex mechanism and autoantibody mechanism. Prototype drugs are penicillin, quinidine and alpha-methyldopa, respectively. Symptoms are mild to moderate in cases of hapten and autoantibody mechanisms and ameliorate by withdrawal of the drugs. Hemolytic anemia due to ternary mechanism may have severe even fetal symptoms, including hemoglobinemia and hemoglobinuria. Some antineoplastic agents can cause hemolytic anemia that resembles the hemolytic uremic syndrome. The prototype drug is mitomycin.
3rd Department of Internal Medicine, Akita University School of Medicine.
A
A
Miura
D000368:Aged; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000276:immunology; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006241:Haptens; D006801:Humans
D006241:Haptens